The Consolidated Appropriations Act of 2021 (CAA 2021) opened the door to class action lawsuits against employer-sponsored health plans in several ways. Most notably by expanding fiduciary obligations, increasing required disclosures, and creating a paper trail that plaintiffs can exploit.

Now, the recent surge in lawsuits focusing on ERISA fiduciary obligations is proving that plan sponsors concerned about their litigation risk had right to be worried.

Plan participants and plaintiff firms are increasingly alleging that employers:

The most significant example so far is the Johnson & Johnson (J&J) lawsuit. Originally filed in February 2024, this new and novel legal case argues the company failed their “duty of prudence” when selecting a pharmacy benefits manager (PBM) and negotiating drug pricing.

Lewandowski v. Johnson & Johnson: A Wake-Up Call for Health Plan Fiduciaries

Overview: This class action lawsuit filed by a J & J employee principally involves mismanagement of prescription-drug benefits. The lawsuit claims J & J breached their fiduciary duties by failing to prudently select a pharmacy benefit manager (PBM) and by mismanaging J & J’s prescription-drug benefits program by failing to negotiate favorable pricing.

In a noteworthy move, the lawsuit also seeks to hold specific individuals within Johnson & Johnson personally liable as fiduciaries, including several HR executives and 20 members of the Pension & Benefits Committee.

Lawsuit Status as of Aug 1, 2025:

The initial complaint was dismissed earlier this year for lack of standing. An amended complaint is currently under court review.

Implications for Self-Funded Plan Sponsors

The case marks one of the first major legal tests of how ERISA fiduciary rules apply to health plans post–Consolidated Appropriations Act of 2021. It also signals a new era of litigation risk for employers who don’t actively manage vendor performance and pricing transparency.

While the case is ongoing, it’s a clear reminder and warning for employers.

Fiduciary responsibilities extend to vendor management and cost oversight—especially around pharmacy benefits. Employers should review all their fiduciary obligations and maintain robust fiduciary procedures.

The lawsuit claims also underscore how important it is for employers to obtain clear and complete compensation disclosures from all service providers to understand any potential conflicts of interest

Fiduciaries and Their Duties Under ERISA

A fundamental issue is that many companies don’t know or misinterpret who exactly holds fiduciary responsibilities, and what those obligations mean.

Per the U.S. Department of Labor, fiduciaries are those persons or entities with discretionary control or authority over plan management or assets, and/or responsibility for plan administration.

Their responsibilities and duties include:

 

The Significance of “Acting Prudently” as a Fiduciary

Acting prudently is the primary responsibility of fiduciaries under ERISA, requiring specialized knowledge and expertise. So first and foremost, employers who lack this internal expertise must engage qualified professionals and document their rationale for doing so. Other key practices:

 

Homestead’s Role as a Claims Fiduciary

As a third-party administrator, Homestead serves as the claims fiduciary authorized to make decisions on claim processing and payment.

Our fiduciary duty is limited to claims-related actions. We do not share the full fiduciary obligations of the employer or plan sponsor but are legally required to:

Steps and Support to Reduce Your Risk

To minimize litigation risk, we recommend the following actions and can provide additional information and guidance if you need help getting started or have questions.

 

Count on Homestead as Your Fiduciary Compliance Partner

Navigating fiduciary obligations under ERISA is complex and the stakes are high. Contact us to learn more.